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Objective: We determined whether baseline depressive symptoms, knee-related conﬁdence and general
psychological distress inﬂuenced changes in pain and function during 2 years of follow-up.
Design: We included persons in the Osteoarthritis Initiative (OAI) dataset with baseline pain of 1 or
greater on a 0e10 scale in at least one knee and no knee or hip surgery during the 2-year follow-up
(n¼ 3407). The four outcome variables were repeated chair standing, 20 m walk and Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC) Pain and Disability. Linear mixed effects
models assessed the association of each mental health variable with the yearly change in each baseline
adjusted outcome measure after controlling for covariates.
Results: Depressive symptoms were signiﬁcantly predictive of worsening in most outcomes. The
magnitude of worsening predicted for each year was small. For example, the dichotomized WOMAC Pain
model indicated that depressed persons experience more rapid worsening than non-depressed persons
at an average rate of 0.59 WOMAC points per year (95% CI 0.176, 1.013, P¼ 0.005). Similar signiﬁcant but
very small effects of depressive symptoms on other outcomes were observed. Knee conﬁdence was not
predictive of change. General psychological distress was predictive of change in 20-m walk and WOMAC
Pain.
Conclusions: The most consistent psychological predictor of yearly worsening was baseline depressive
symptoms. Although a statistically robust predictor of outcome, given that change was very small and
highly dependent on baseline status, our results indicate that a considerable degree of persistent
depressive symptoms would be required to have a meaningful effect on future self-reported outcome.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Osteoarthritis (OA) and soft tissue disorders of the lower
extremities are a major burden for individuals and society. Knee
pain is particularly commonwith a period prevalence of 18.1% of US
men and 23.5% of US women aged 60 years and older reporting
pain on most days during the previous 6 weeks1. Knee OA also is
common with an estimated prevalence of between 12%2 and 37%3
for persons aged 60 and older. As a result, many efforts have been
made to identify and quantify the role of various risk factors in knee
symptom or disease progression4e12. Most of these studies haveDaniel L. Riddle, Department
ity, West Hospital Basement,
4, USA. Tel: 1-804-828-0234;
s Research Society International. Pbeen devoted to the identiﬁcation of demographic, biomarker and
disease characteristics, surgical history or other musculoskeletal
characteristics that predispose persons to worsening. Only a few
studies, to our knowledge, have explored the role of mental health
in predicting functional decline or worsening pain in samples of
persons with knee pain or knee OA6e8,11,13,14. The potential role of
mental health in the progression of knee pain and functional
decline is important because mental health is modiﬁable and
therefore may be a target for interventions.
Belo and colleagues found that fear of movement independently
predicted persistent symptoms 1 year following baseline measures
taken on 480 persons with knee pain6. Dunlop and colleagues
found that depressive symptoms as measured with the Center for
Epidemiologic Studies Depression Scale (CES-D)15 independently
predicted functional decline (adjusted Odds Ratio (OR) 1.3, 95%ublished by Elsevier Ltd. All rights reserved.
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4922 persons with self-reported arthrits7. Depression was not
found to independently predict outcome for patients with knee
pain or arthritis in studies by Mallen and colleagues8, Sharma
et al.11, Jinks et al.13, and Holla and colleagues14.
The knee pain/OA literature suggests poor mental health
impacts future function but the data are inconsistent. More
research is needed to identify and to quantify the extent to which
modiﬁable mental health constructs (e.g., self conﬁdence) and
disorders (e.g., depression) potentially inﬂuence future pain and
function in persons with knee pain. The purposes of this studywere
to determine whether baseline depressive symptoms, knee-related
conﬁdence and general psychological distress inﬂuenced yearly
change in pain, functional status and physical performance during
2 years of follow-up. We hypothesized that depressive symptoms
would be the strongest and most consistent predictor of yearly
worsening.
Materials and methods
The Osteoarthritis Initiative (OAI)
The OAI is a publicly and privately funded prospective 4-year
longitudinal cohort study designed to identify and follow diverse
cohorts of persons aged 45e79 years to examine the onset and
progression of knee OA. Subjects received no treatment as part of
the study. The study was approved by the Institutional Review
Board at the University of California, San Francisco.
The sample is community based to the extent that only 6.5% of the
sample reported seeing a doctor or otherhealthprofessional for knee
arthritis. No treatment was provided in the OAI but subjects were
asked to self-report any treatments received in their communities.
Subjects were recruited from: (1) the University of Maryland,
Baltimore, Maryland, (2) Ohio State University, Columbus, Ohio,
(3) University of Pittsburgh, Pittsburgh, Pennsylvania, and
(4) Memorial Hospital of Rhode Island, Pawtucket, Rhode Island.
OAI study sample
Exclusion criteria were the presence of rheumatoid arthritis,
bilateral knee arthroplasty or preexisting plans to undergo bilateral
(not unilateral) knee arthroplasty in the next 3 years, bilateral
Osteoarthritis Research Society International (OARSI) stage 3
(severe) knee OA16, positive pregnancy test, inability to provide
a blood sample, use of ambulatory aids other than a single straight
cane for more than 50% of the time, co-morbid conditions that
might interferewith 4-year participation, unlikely to reside in clinic
area for at least 3 years, current participation in a double-blind
randomized controlled trial, and being unwilling to sign informed
consent. In addition, because the study measured Magnetic
Resonance Imaging (MRI) based changes in a small subsample of
subjects, men weighing more than 130 kg and women weighing
more than 114 kg were excluded because they were unable to
undergo 3.0 Tesla MRI (2295 persons excluded). In total, 27%
(N¼ 4796) of those screened (N¼ 17,457) were admitted to the
study. Common reasons for exclusion were drop outs after the
initial telephone screen (N¼ 3321) and admission quotas beingmet
for certain age and gender categories (N¼ 2954).
Current study sample
The OAI combined incidence and progression sub-cohorts
comprise 4674 persons. Our exclusionary criteria were the
following: (1) no pain in either knee at baseline as measured with
a 0e10 verbal pain rating scalewith 0 representing “no pain” and 10representing “pain as bad as you can imagine”, (2) knee or hip
surgery during the follow-up period. We only included persons
reporting pain in one or both knees to capture those persons who
may seek out healthcare for a knee problem. We excluded persons
with knee or hip surgery during the follow-up period to avoid con-
founding due to potentially substantial changes in their lower
extremity related pain or function subsequent to surgery. Thus 1069
persons were excluded because they reported no baseline pain in
either knee and an additional 198 persons were excluded because
they underwent either hip or knee surgery during the follow-up
period. The total sample for the current study was 3407 persons.
Outcome variables of interest
We chose two performance-based measures and two self-report
measures. The physical performance measures we used were the
ﬁve chair stands test (standing from a chair ﬁve times as quickly as
possible) measured in stands/s and the 20 m walk test (at usual
pace) measured in m/s. Both measures are highly reliable with
Intraclass Correlation Coefﬁcients (ICCs) ranging from 0.93 to 0.98
within and between testers obtained on patients with moderate to
severe knee OA17. These tests were chosen because they represent
commonly performed daily activities by persons with knee OA and
require differing amounts of endurance, strength and balance.
Operations manuals for all data collected in the OAI study can be
found at http://oai.epi-ucsf.org/datarelease/operationsManuals.asp.
For self-report outcome measures, we used the Pain and
Disability sub-scores from the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) scale (Likert 3.1),
a commonly used and validated scale for patients with knee OA.
The WOMAC Pain scale is scored 0e20 with higher scores indi-
catingmore severe painwhile theWOMAC Disability scale is scored
0e68 with higher scores indicating worse disability18e21. Although
OAI investigators collected WOMAC scores for the left and right
knees, the WOMAC was originally designed as a person-level self-
report measure with questions that ask about functional capability
associated with activities involving bilateral knee function such as
shopping, bending to the ﬂoor and standing18,19. We reasoned that
the higher WOMAC score of the two knees reported at each session
best reﬂected the knee-related pain or disability for that person,
and therefore used the higher of the left and right sided WOMAC
scores for each session.
Predictor variables
Key predictor variables of interest
The key predictor variables were the following: (1) the
commonly endorsed SF-12 Mental Component Summary (MCS)22.
This 12-item self-report instrument is norm referenced (mean of 50
for general US population) with scores ranging from 0 to 68 with
higher scores indicating higher mental function23. (2) The 20-item
CES-D (CES-D 20). The CES-D is commonly used and ranges from
0 to 60 and a score of 16 or higher is generally accepted as the cut-
score for indicating probable clinical depression15,24e26. (3) The
single-item knee conﬁdence scale from the Knee Injury and
Osteoarthritis Outcome Score (KOOS) Quality of Life Scale. The item
asks “How much are you troubled with lack of conﬁdence in your
knee(s)?” The item is scored on a Likert scale from 0 (not at all) to 4
(extremely). We chose this item because, in our experience,
patients with knee pain sometimes report a lack of conﬁdence in
their knees and we suspected that lower conﬁdence may impact
negatively on future pain or function. We found no reliability
evidence for this single KOOS item but similar Likert-type single-
item scales of complex health constructs demonstrate reliability in
the 0.7e0.8 range27.
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The approach to selecting covariate predictors was to identify
variables found to be associated with knee pain or functional loss
from large sample longitudinal studies of persons with either knee
pain or knee OA4e11. Predictor variables examined represent the full
depth and breadth of data encompassing demographic and socio-
economic characteristics, variables measuring general health,
arthritis speciﬁc health and physical examination results.
Age, gender, race, annual income and social support were the
demographic and socioeconomic variables. The degree of social
support indicated the number of persons living in the household.
The validated Charlson comorbidity index, scored 0e3128, Body
Mass Index (BMI) and Physical Activity Scale for the Elderly (PASE)29,
a validated self-report measure of daily function were included.
Subjects completed a variety of arthritis-related health
measures including symptom duration, history of traumatic knee
injury, whether the subject had generalized OA and whether the
person had bilateral knee OA as determined by weight-bearing
ﬁxed ﬂexion radiographs30.
Quadriceps and hamstring muscle torque tests (Newton cm/
bodyweight in kg) each coded as the weakest score were included
because of the association between thighmuscle strength and OA31.
Varus and valgus alignment, measured in degrees was coded as the
knee with the most severe alignment11. The extent of knee ﬂexion
contracture, measured in degrees, was coded as the knee with the
worst knee ﬂexion contracture.
Data analysis
To assess the inﬂuence of each baseline psychological factor on
the change of each outcome variable measured on a continuous
scale, linear mixed effects model was used to model the outcome
(measured at baseline and year 1 and year 2) as a function of time
(t¼ 0, 1, 2). Linear mixed effects model is a regression model that is
commonly used to assess effects of independent variables on the
outcome variable. Speciﬁcally, it is adopted here to take into
account the correlations between repeated measurements on the
same individual. Also the intercept and slope parameter that
measures the change per year are assumed to be normally
distributed random effects. The mean values of the random effects
allow estimation of population average trend across all individuals,
whereas the variances of the random effects allow different varia-
tions from the population average for different individuals. The
assumption of a linear trend over the 2-year follow-up was
examined by graphical inspection and by testing the statistical
signiﬁcance of the term for second order of time. Both showed that
the linear assumption was acceptable.
Baseline pain or functional status is the key determinant for
a person’s pain or function measures at follow-up visits, and indi-
viduals with different levels of baseline pain or functional status
were expected to have different levels of change during the 2 years
of follow-up8,9. Baseline pain or function is an important
confounder when estimating effects of psychological variables and
was adjusted for in all analyses. To simplify interpretation, indi-
viduals were ﬁrst categorized using quartiles of the baseline
outcome measurements. This grouping variable and its interaction
with time were included in the model as ﬁxed effects predictor
variables in order to account for the variation in trends determined
bybaseline pain or functional status. The psychological factor and its
interaction with time were also treated as ﬁxed effects to estimate
the population average change of the outcome variable associated
with the psychological factor, after controlling for the baseline pain
or function level. All psychological factors were measured on
continuous scales. Depression is a disorder that occurs along
a continuum25,32, but because the CES-D depression measure has
a widely used and accepted cutpoint of 16 for probable clinicaldepression, we also modeled depression on this dichotomous
scale15.
The effect of each psychological factor on pain or functional
status change was estimated in multiple models that controlled for
potential confounding variables. Speciﬁcally, a linear mixed effect
model (as described above) for each confounding variable was ﬁt,
and if the confounding variable had signiﬁcant inﬂuence on change
in outcome measure with P-value< 0.15, the variable was included
in the multiple models.
The analyses were based on observed data likelihood and
missing follow-up data were treated as missing at random (MAR),
following Rubin’s deﬁnition of missing data mechanisms33,34. It
was observed that subjects with higher levels of pain and poorer
function at baseline were more likely to drop out. Given the
determinative effect of baseline pain and function status on follow-
upmeasures, the missingness at follow-upmay depend on baseline
measurements but will likely not depend on the unobserved
follow-up values. Therefore the MAR assumption was accepted
after adjusting for baseline pain or function status. All analyses
were conducted in Statistical Analysis Software (SAS) 9.2 using
two-sided tests and signiﬁcance level 0.05. The proportion of
explained variance for each model was calculated35.Results
Baseline characteristics for the 3407 participants are reported in
Table I. Summary scores over the 2-year period for each outcome
measure, reported in quartiles, are summarized in Table II. For the
WOMAC Pain and Function scores, the ﬁrst quartile of scores
represents the best scores (least pain and highly functioning) while
the fourth quartile represents subjects who had the worst scores
(highest pain and lowest functioning). For the repeated chair stand
and 20 m walk test, the ﬁrst quartile represents subjects with the
worst scores while the fourth quartile indicates the best
performance.
The loss to follow-up rate can be derived from Table II. For
example, 3405 of the 3407 (99.9%) subjects included in this study
completed the baseline WOMAC Pain score, 3146 (92.3%)
completed the 1-year follow-up and 3007 (88.3%) completed the
2-year follow-up. Subjects lost to follow-up reportedmore pain and
functional loss and had more impaired performance at baseline
than subjects with complete data (see Table III).Yearly changes in WOMAC Pain and Disability
Results for univariatemodels adjusted for baselineWOMAC Pain
or Disability scores and multiple models adjusting for all potential
confounders appear in Table IV. After adjusting for multiple cova-
riates, the Time CES-D depression interaction was highly signiﬁ-
cant (P¼<0.001) for predicting 1 and 2-year changes in WOMAC
Pain and Function. For example, each point increase in depressive
symptoms at baseline resulted in a 0.02 point average increase in
WOMAC Pain scores each year. Using the dichotomized CES-D
scores, WOMAC Pain scores of depressed persons increased by
0.59 points each year and WOMAC Disability scores increased by 2
points each year compared to non-depressed persons.
Baseline conﬁdence, measured by question #3 from the KOOS
Quality of Life Scale was not predictive of change in WOMAC
Pain (P¼ 0.148) or Disability (P¼ 0.12). The multiple model
using the baseline SF-12 MCS score signiﬁcantly predicted 1 and
2-year changes in WOMAC pain (P¼ 0.025). The SF-12 MCS score
(P¼ 0.106) was not signiﬁcantly related to 1 and 2-year WOMAC
Disability change scores. The proportion of explained variance in all
models ranged from 23.3% to 28.5%.
Table I
Characteristics of 3407 persons in the study
Variables Mean (sd, min, max) or N (%)
Demographic
Age in years, mean (sd, min, max) 60.62 (9.04, 45, 79)
Female (%) 2015 (59.1)
Race/ethnicity (%)
Hispanic 41 (1.2)
Other non-white 63 (1.9)
White or Caucasian 2599 (76.4)
Black or African American 713 (21.0)
Asian 28 (0.8)
Education (%)
Less than high school 119 (3.5)
High school 428 (12.7)
Some college 800 (23.7)
College graduate 713 (21.1)
Some graduate school 279 (8.3)
Graduate degree 1041 (30.8)
Marital status (%)
Married 2268 (67.1)
Widowed 269 (8.0)
Divorced 477 (14.1)
Separated 62 (1.8)
Never married 304 (9.0)
Annual income< $50,000 (%) 1278 (40.6)
Number living in household 1.27 (1.14, 0, 6)
General health
Comorbidity score 0.41 (0.85, 0, 7)
BMI 28.85 (4.86, 17.2, 48.7)
Subcohort
Incidence 2164 (63.5)
Progression 1243 (36.5)
PASE 160.88 (82.68, 0, 526)
Arthritis health
Modiﬁed Kellgren Lawrence knee OA grade (%)
Normal Right 630 (18.6), Left 663 (19.6)
Possible Right 1176 (34.8), Left 1196 (35.3)
Deﬁnite mild Right 670 (19.8), Left 652 (19.2)
Moderate Right 698 (20.6), Left 691 (20.4)
Severe Right 210 (6.2), Left 187 (5.5)
Generalized OA (%) 248 (7.7)
Bilateral knee OA (%) 1239 (36.4)
Ever have surgery on right or left knee (%) 810 (23.8)
Symptom duration in years (%)
None 931 (27.3)
1 Year or less 372 (10.9)
2e5 Years 947 (27.8)
Longer than 5 years 1157 (34.0)
History of traumatic knee injury to either
knee (%)
1564 (46.4)
Weakest quadriceps torque (N cm/kg
bodyweight)
117.20 (45.33, 7, 339)
Most severe varus/valgus knee alignment
(degrees)
3.53 (2.71, 0, 20)
Most severe knee ﬂexion contracture
(degrees)
2.0 (3.35, 0, 40)
Psychological predictor variables
CES-D depression 7.11 (7.3, 0, 57)
CES-D 16 (%) 395 (11.8%)
SF-12 mental health 53.18 (8.54, 9.81, 72.86)
Troubled with lack of knee conﬁdence (%)
Not at all 1341 (44.7)
Mildly 982 (32.7)
Moderately 481 (16.0)
Severely 135 (4.5)
Extremely 64 (2.1)
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The univariate and multiple models for predicting changes in
1- and 2-year 20-m walking pace and repeated chair stand pace
scores appear in Table IV. For example, the Time CES-D depres-
sion score interaction was signiﬁcant (P< 0.001) indicating that for
every point increase in depressive symptoms, an average reduction
of 0.0009 m/s in 20-m walking pace occurs each year. The KOOS
conﬁdence question was not a signiﬁcant predictor of future 20-m
walking pace (P¼ 0.068) or repeated chair stand pace (P¼ 0.218).
The SF-12 MCS score Time interaction was signiﬁcant (P¼ 0.029)
indicating that for every point increase in MCS score, 20-mwalking
pace increased by 0.0004 m/s, on average, per year. Tables of the
complete multiple models for predicting yearly WOMAC Pain and
20 m walk changes appear in the Supplementary ﬁle.
Discussion
Our ﬁndings indicate that of the three psychological measures
examined in the OAI study, depressive symptoms as measured with
the CES-D is themost robust independent predictor of yearly changes
in self-reported pain, disability, walking pace and chair stand
performance. Themagnitude of the effect of depressive symptoms on
each outcome is small, particularly for the performance-based
measures to the extent that yearly reductions in performance-based
measures, while statistically robust, are not clinically meaningful.
We use two examples from Table IV to illustrate the prognostic
impact of depression on future WOMAC Pain and Function. For
example 1, the multiple Beta coefﬁcient for the dichotomized
WOMAC Pain model from Table IV indicates that, relative to non-
depressed persons, those with depression (CES-D 16) can expect
to experience more rapid worsening at the average rate of 0.6
WOMACpoints per year. For example 2, themultiple Beta coefﬁcient
for the dichotomized WOMAC Disability model from Table IV indi-
cates that, relative to non-depressed persons, thosewith depression
can expect to have more rapid worsening at an average rate of
approximately 2 points per year. Both examples illustrate that the
patient’s depression would need to persist for multiple years to
produce an appreciable impact on future pain and disability.
Our study has several strengths and these include a large sample
size, an extensive and well deﬁned list of covariates and an 88%
follow-up over the 2-year period.We also reported the yearly impact
of each mental health measure in the measurement units of interest
(e.g.,WOMACPainpoints) to allow forclear interpretationandclinical
application. However, our study also had several limitations. The
magnitudeofyearlyworseningpredictedbytheCES-DandSF-12MCS
scores was very small, primarily because changes over the 2 years
were also small and were in the direction of group-level improve-
ments. We suspect that much of these group-level improvements,
particularly for theworst scoring quartiles are due to selective loss to
follow-upparticularly for personswithhigher initial disability or pain
(Table III). Nevertheless, since follow-up pain or performance highly
depended on baseline status, we adjusted for baseline function or
pain status in all analyses. Therefore, theMAR assumption on loss-to-
follow-upwasacceptableandparameterestimatesusing theadjusted
linear mixed effect models are unbiased. Some improvement also
may be attributed to healthmonitoring by interested researchers and
participation in a large federally funded study.
Improvement over time in large cohorts with knee pain or OA is
not unusual. Belo and colleagues noted dramatic improvement in
patients with knee pain over a 1-year period6. Holla and colleagues
reported an approximate 1 point mean improvement on a 100
point scale with large variation (Standard Deviation (SD)¼ 9.84) in
WOMAC Disability scores for 832 persons with knee pain over
a 2-year period14. Given that our sample showed improvements
Table II
Descriptive statistics for the longitudinal data for key outcome variables
Measure by quartile Baseline score
Mean (SD)
1-Year follow-up score
Mean (SD)
2-Year follow-up score
Mean (SD)
Baseline WOMAC Pain*
0e5 2.16 (1.65) (n¼ 2350) 2.26 (2.45) (n¼ 2227) 2.36 (2.62) (n¼ 2150)
6e10 7.66 (1.39) (n¼ 795) 5.78 (3.52) (n¼ 709) 5.66 (3.63) (n¼ 663)
11e15 12.37 (1.23) (n¼ 228) 9.66 (4.02) (n¼ 183) 9.48 (4.30) (n¼ 170)
16e20 17.03 (1.31) (n¼ 32) 12.44 (5.63) (n¼ 27) 11.08 (5.17) (n¼ 24)
All 4.27 (3.76) (n¼ 3405) 3.57 (3.66) (n¼ 3146) 3.56 (3.67) (n¼ 3007)
Baseline WOMAC Disability*
0e17 6.08 (5.30) (n¼ 2342) 6.20 (7.71) (n¼ 2214) 6.32 (7.91) (n¼ 2121)
18e34 24.31 (4.77) (n¼ 785) 18.75 (11.07) (n¼ 693) 18.51 (11.81) (n¼ 655)
35e51 39.79 (4.32) (n¼ 233) 29.49 (13.77) (n¼ 188) 28.97 (14.39) (n¼ 172)
52e68 57.40 (5.26) (n¼ 24) 44.28 (14.99) (n¼ 15) 46.66 (11.64) (n¼ 15)
All 13.03 (12.38) (n¼ 3384) 10.80 (11.89) (n¼ 3126) 10.66 (11.97) (n¼ 2979)
Baseline 20 m walk testy
0.24e1.164 m/s 1.04 (0.12) (n¼ 849) 1.11 (0.17) (n¼ 694) 1.10 (0.18) (n¼ 620)
1.165e1.308 m/s 1.24 (0.04) (n¼ 848) 1.28 (0.13) (n¼ 745) 1.26 (0.13) (n¼ 701)
1.309e1.451 m/s 1.38 (0.04) (n¼ 850) 1.38 (0.13) (n¼ 774) 1.36 (0.13) (n¼ 715)
1.452e2.17 m/s 1.59 (0.12) (n¼ 848) 1.54 (0.17) (n¼ 755) 1.52 (0.15) (n¼ 736)
All 1.31 (0.22) (n¼ 3395) 1.33 (0.22) (n¼ 2975) 1.32 (0.21) (n¼ 2780)
Baseline repeated chair standy
0.10e0.38 stands/s 0.31 (0.06) (n¼ 743) 0.38 (0.10) (n¼ 559) 0.39 (0.10) (n¼ 506)
0.39e0.46 stands/s 0.43 (0.02) (n¼ 762) 0.45 (0.10) (n¼ 638) 0.46 (0.10) (n¼ 597)
0.47e0.56 stands/s 0.51 (0.03) (n¼ 884) 0.52 (0.10) (n¼ 769) 0.52 (0.10) (n¼ 746)
0.57e1.65 stands/s 0.69 (0.12) (n¼ 842) 0.64 (0.15) (n¼ 744) 0.64 (0.14) (n¼ 716)
All 0.49 (0.15) (n¼ 3231) 0.51 (0.15) (n¼ 2785) 0.51 (0.15) (n¼ 2650)
* Lower scores indicate less pain or disability.
y Lower scores indicate compromised performance.
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a statistically robust and consistent predictor of worsening,
particularly for more depressed patients. This requires an
assumption that similar changes would occur beyond the time of
our follow-up and this may not be the case. In addition, our models
using the continuous depression measure may be potentially
limited because the relationship between depression score and
changes in pain and functional status may not be linear.
Evidence collected on a variety of different types of patients has
indicated that pain and depression have reciprocal effects on one
another such that current depression or changes in depression
predicts subsequent pain and vice versa32,36e38. The effects we
found were robust and in the direction of current depression
inﬂuencing future pain and functional status. We acknowledge that
there are likely to be reciprocal and confounding effects of pain and
potentially functional status on depression and that we only
assessed and quantiﬁed the effects in the direction of depression
inﬂuencing future pain and function. A recently published trial
suggests that optimal depression and pain treatment in depressed
arthritic patients reduces pain and enhances function39. It is likelyTable III
Comparison of baseline outcome scores of subjects with and without missing data at eit
Variables Baseline scores for subjects without missing data
Mean (SD)
1-Year follow-up measures
WOMAC Pain 4.10 (3.66) (n¼ 3146)
WOMAC Disability 12.39 (11.89) (n¼ 3110)
Repeated chair stand 0.50 (0.15) (n¼ 2710)
20 m Walk test 1-year 1.32 (0.22) (n¼ 2968)
2-Year follow-up measures
WOMAC Pain 4.04 (3.62) (n¼ 3007)
WOMAC Disability 12.26 (11.86) (n¼ 2963)
Repeated chair stand 0.50 (0.15) (n¼ 2565)
20 m Walk test 1.32 (0.21) (n¼ 2772)
* Mean diff. is the mean difference between those with missing data and those witho
scores than those without missing data while negative numbers indicate that those withthat treatments directed toward both pain and depressionwill have
superior effects to treatment directed only to pain or to depression
in patients with both musculoskeletal pain and depression.
We were unable to test for the potential impact of important
personality traits such as neuroticism or perceived helplessness40
or mental health constructs such as pain catastrophizing or self
efﬁcacy41,42. It is possible that these or other traits and constructs
may impact future pain and function in patients with knee pain.
Finally, only 27% of persons screened were actually entered into the
study and this selection bias limits generalizability particularly to
persons above MRI weight limits.
Prevalence of depression in persons with chronic arthritic or
knee pain ranges from 15% to 20%32. Prevalence of depression of
11.8% in our study is slightly lower than these estimates but also
support the clinically important link between co-occurring pain
and depression. Cross sectional correlations among baseline
depression and WOMAC Pain (Pearson r¼ 0.26) and Disability
(r¼ 0.29) in our study were low. These data suggest that subse-
quent changes in pain and disability were not simply attributable to
high baseline correlations among pain, disability and depression.her the 1- or 2-year follow-up
Baseline scores for subjects with missing data
Mean (SD)
Mean diff.* t Test
6.26 (4.36) (n¼ 259) 2.16 <0.001
20.29 (15.23) (n¼ 274) 7.90 <0.001
0.44 (0.16) (n¼ 521) 0.06 <0.001
1.25 (0.25) (n¼ 427) 0.07 <0.001
5.97 (4.29) (n¼ 398) 1.93 <0.001
18.49 (14.45) (n¼ 421) 6.23 <0.001
0.44 (0.15) (n¼ 666) 0.06 <0.001
1.25 (0.24) (n¼ 623) 0.07 <0.001
ut missing data. Positive numbers indicate that those with missing data had higher
missing data had lower scores than those without missing data.
Table IV
Summary of key ﬁndings from modiﬁed univariate and multivariate models adjusting from time. Each model describes the association between the psychological predictor
variable and yearly changes in each key outcome measure over 2 years
Controlling only for Baseline Outcome Measure Controlling for Baseline Outcome Measure and Confounding
Variables*
Estimate 95% CI Pr> t E.V.y Estimate 95% CI Pr> t E.V.y
Time CES-D depression score
WOMAC Pain 0.022 0.013, 0.031 <0.001 26.7% 0.019 0.008, 0.030 <0.001 21.0%
WOMAC Disability 0.056 0.029, 0.083 <0.001 28.5% 0.053 0.017, 0.088 0.003 22.0%
20-m Walk 0.0008 0.001, 0.0004 <0.001 23.3% 0.0009 0.001, 0.0004 <0.001 26.9%
Repeated chair stand 0.0004 0.0008, 0.0001 0.018 25.8% 0.0005 0.0008, 0.00007 0.022 26.8%
Time CES-D dichotomized depression score (16)
WOMAC Pain 0.362 0.162, 0.563 <0.001 26.6% 0.59 0.176, 1.013 0.005 21.0%
WOMAC Disability 0.77 0.157, 1.381 0.014 28.5% 1.93 0.590, 3.271 0.005 22.0%
20-m Walk 0.012 0.022, 0.003 0.01 23.3% 0.01 0.028, 0.008 0.28 26.9%
Repeated chair stand 0.008 0.015, 0.0002 0.059 25.8% 0.013 0.029, 0.002 0.10 26.8%
Time SF-12 MCS score
WOMAC Pain 0.014 0.021, 0.006 <0.001 26.5% 0.010 0.019, 0.001 0.025 20.9%
WOMAC Disability 0.032 0.054, 0.009 0.006 28.0% 0.024 0.052, 0.005 0.106 21.8%
20-m Walk 0.0004 0.00002, 0.0007 0.039 23.5% 0.0004 0.00005, 0.0008 0.029 27.0%
Repeated chair stand 0.0002 0.0005, 0.0001 0.218 25.6% 0.00008 0.0004, 0.0003 0.647 26.6%
Time conﬁdence measure from KOOS
WOMAC Pain 0.169 0.101, 0.237 <0.001 26.3% 0.062 0.022, 0.146 0.148 21.1%
WOMAC Disability 0.395 0.198, 0.610 <0.001 27.9% 0.214 0.056, 0.484 0.120 21.7%
20-m Walk 0.005 0.008, 0.002 <0.001 23.6% 0.003 0.006, 0.0002 0.068 27.1%
Repeated chair stand 0.003 0.005, 0.0007 0.012 25.5% 0.002 0.004, 0.001 0.218 26.7%
* All models adjusted for the following variables depending onwhether theymet criteria for model entry of P< 0.10 for eachmodel; baseline outcome score in quartiles, sex,
gender, race, comorbidity, income, knee OA status, BMI, presence of generalized OA, longest knee pain duration, history of knee injury, PASE score, most severe varus/valgus
alignment, weakest knee extensor strength, most severe knee ﬂexor contracture. In addition, all variables included in the models were adjusted for time.
y E.V., explained variance for each of the models.
D.L. Riddle et al. / Osteoarthritis and Cartilage 19 (2011) 1095e11011100Two studies examined similar heterogeneous mixes of persons
with and without conﬁrmed knee OA to determine if baseline
depression was an independent predictor of outcome6,8,14. Mallen
and colleagues8 and Holla et al.14 found that depressive symptoms
were not predictive of outcome. We suspect that the reason for
differences between our study and those reported by others is that
we had a much larger sample and we treated the prognostic vari-
ables as continuous variables in most analyses.
In conclusion, our study has implications for clinicians in that
persistent depressive symptoms may lead to self-reported pain and
function worsening for patients with knee pain. Actual physical
performance does not appear to be impacted in a clinically mean-
ingful way by depression or general psychological distress. Future
studies are needed that examine the costs and effectiveness of
interventions designed to treat depression and pain in persons with
knee pain and co-occurring depression. Studies of potential medi-
ating effects of changes in depression and pain on outcome in
groups of patients with higher levels of depression are also needed.
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